The Narrowing: Spinal Stenosis, Epidural Injections and the Accumulated Condition Under Pressure

Dr Jack Parry 3 May 2026

keywords: spinal stenosis ligamentum flavum epidural corticosteroid oligodendrocyte myelin compression pain access healthcare

Someone close to me has degenerative spinal stenosis. Her pain increases with every passing month. Her mobility decreases in parallel. The neurologists who might help her have declined to see her because she has no private health insurance. She is considering an epidural injection, and she asked what the Myelin Mind has to say about it.

I do not give medical advice. I hold a PhD, not a medical degree. What follows is biology, not clinical guidance. But the Myelin Mind does have something precise to say about stenosis and about epidurals, and it is not what I expected when I began looking.

Degenerative spinal stenosis is the narrowing of the spinal canal. The canal is the bony tunnel through which the spinal cord travels from the brainstem to the lumbar region, carrying the white matter pathways that are, on the Myelin Mind account, the accumulated myelinated condition of the embodied self. Every signal that connects the body to the brain travels through this tunnel. Every instruction the brain sends to the muscles passes through it in the opposite direction. It is, literally, the main corridor of the peripheral-central chiasm.

The narrowing is caused primarily by hypertrophy of the ligamentum flavum, the elastic ligament forming the posterior wall of the spinal canal. In a healthy spine the ligament is two to four millimetres thick. Under chronic mechanical stress, as the discs degenerate and the vertebrae shift, the ligament undergoes a transformation: its elastin fibres break down and are replaced by collagen through a fibrotic process driven by TGF-beta signalling and chronic inflammation. It thickens. In severe cases it reaches seven to fifteen millimetres. What was a soft elastic boundary becomes a rigid, bulging wall pressing inward on the cord and its nerve roots.

The body is closing its own corridor. Not through malice or error but through the same mechanical stress response that produces scar tissue anywhere else: fibrosis as the default repair mechanism when elasticity fails. The ligamentum flavum, which evolved to flex and recoil with every movement of the spine, is instead hardening in place.

The Myelin Mind consequence is direct and measurable. Constant compression of the spinal cord produces oligodendrocyte apoptosis and subsequent demyelination of adjacent neurons. The microvascular structures that supply blood and lactate to the myelinating glia are compressed along with the cord itself. The result is ischaemia: the oligodendrocytes and the axons they maintain are deprived of their metabolic supply, and without that supply the accumulated myelinated condition degrades. In severe and sustained stenosis, Wallerian degeneration of the posterior columns and posterolateral tracts follows, cystic cavitation develops in the cord, and the accumulated condition is not merely disrupted but progressively destroyed from outside by a mechanical force.

This is the most literal possible sense in which the accumulated myelinated condition can be threatened. Not through autoimmune attack, as in MS. Not through pharmacological interference, as in the conditions the site has described elsewhere. Through the physical narrowing of the space in which the accumulated condition lives.

The pain of stenosis is neuropathic, generated partly at the compressed nerve roots, partly through central sensitisation as the accumulated myelinated condition of the pain pathways inscribes the chronic signal. The immobility is the consequence of motor pathways being progressively interrupted. Both worsen because the compression continues and the oligodendrocyte apoptosis it produces is not reversed by the body’s own repair mechanisms. Unlike peripheral Schwann cells, CNS oligodendrocytes have limited regenerative capacity. Once the myelinated condition has been damaged by sustained compression, it cannot easily rebuild itself.

The progression, more pain with every passing month, less mobility in parallel, is the biology of an accumulated condition under sustained mechanical pressure, degrading in the corridor that is also closing.

Before describing what an epidural injection does, it is worth naming what it is not. An epidural injection does not go into the spinal cord. It goes into the epidural space: the layer between the dura mater, the outer membrane encasing the cord, and the walls of the vertebral canal. The needle does not penetrate the cord. For lumbar stenosis, which is the most common site in elderly patients, the injection is performed below the level at which the spinal cord ends, around L1 to L2, in the cauda equina region where the cord has already separated into individual nerve roots. The immediate risk of direct cord damage from a lumbar epidural is therefore substantially lower than the framing of “injecting into the spinal cord” implies.

The serious complications that have prompted FDA warnings, spinal cord infarction, paralysis, cortical blindness, are primarily associated with cervical epidural injections, where the cord is present at the injection site and an inadvertent intramedullary injection is possible. For a lumbar injection in an elderly patient with degenerative stenosis, the risk profile is different. This does not mean the procedure is without risk. It means the risk is characterised differently than the framing suggests.

What the corticosteroid does in the epidural space is reduce inflammation around the compressed nerve roots. The inflammatory cytokines that accumulate around compressed nerve tissue amplify pain, contribute to further oedema, and accelerate the fibrotic process in the ligamentum flavum itself. Reducing that inflammation temporarily relieves the pain and can slow the secondary inflammatory damage to the compressed tissue.

The Myelin Mind concern about epidural corticosteroids is not primarily the injection risk. It is the corticosteroid itself.

Corticosteroids suppress OPC differentiation. The same mechanism that makes chronic stress demyelinating, the cortisol elevation that arrests oligodendrocyte precursor cells in their undifferentiated state, operates when corticosteroids are injected directly near the spinal cord. A single injection at the doses used clinically is unlikely to produce significant OPC suppression. But repeated injections, at the frequency sometimes required for sustained pain relief, accumulate that suppressive effect in exactly the tissue that most needs the OPCs to remain capable of remyelination.

The body, in a compressed spinal segment, is already trying to remyelinate around the edges of the damage. Every OPC that differentiates successfully and wraps a surviving axon is a small restitution of the accumulated condition. Repeated corticosteroid injections may relieve pain while simultaneously suppressing the very cellular response that represents the cord’s only available self-repair mechanism. The relief and the suppression are the same injection.

This is not a reason to refuse the injection. For someone whose pain is increasing with every month and whose mobility is already severely compromised, pain relief is not a secondary concern. It is the primary one. Untreated chronic pain produces its own central sensitisation, its own progressive inscription of the pain signal in the accumulated myelinated condition, and its own downstream effects on sleep, cortisol, and the myelination process that sleep is supposed to consolidate.

The honest position is that an epidural injection is a trade: temporary anti-inflammatory relief, with a modest OPC suppression cost, in a situation where the underlying compression is continuing regardless. It treats a consequence while the cause, the narrowing corridor, advances. It is not a solution. For someone with no access to surgical decompression, it may be the only intervention available, and the relief it provides is real and biologically legitimate.

The access question cannot be left unaddressed, because it is not separate from the biology. Chronic pain, sustained cortisol elevation, reduced mobility, restricted sleep, all suppress OPC differentiation and accelerate the degradation of the accumulated myelinated condition. Poverty is demyelinating. Not metaphorically. Through the sustained activation of the stress axis, the disruption of sleep, the restricted access to the movement and genuine encounter that drive activity-dependent myelination, and the foreclosure of the interventions that might slow the mechanical compression.

The neurologists who decline to see patients without private insurance are not making a clinical decision. They are making an economic one. The biological consequence of that decision is borne entirely by the patient’s white matter.

This is not an observation the Myelin Mind can resolve. It is one it is obliged to name.

The Narrowing: Spinal Stenosis, Epidural Injections and the Accumulated Condition Under Pressure

Further Reading

Leave a Reply Cancel reply